Topics

Astellas to acquire Audentes Therapeutics in $3B deal

05:42 EST 4 Dec 2019 | SmartBrief

Astellas Pharma of Japan announced it plans to purchase gene therapy developer Audentes Therapeutics in a $3 billion all-cash -More

Original Article: Astellas to acquire Audentes Therapeutics in $3B deal

NEXT ARTICLE

More From BioPortfolio on "Astellas to acquire Audentes Therapeutics in $3B deal"

Quick Search

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...